Exhibit
23.3
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the inclusion in this Amendment No. 5 to the Registration Statement on Form S-4 and related joint proxy
statement/prospectus of our report dated March 15, 2021, with respect to the consolidated financial statements of Ensysce
Biosciences, Inc. as of December 31, 2020 and 2019 and for the years then ended (which report includes an explanatory
paragraph regarding the existence of substantial doubt about the Company’s ability to continue as a going concern), and
to the reference to us under the heading “Experts” in the joint proxy statement/prospectus which is part of the
Registration Statement.
/s/
Mayer Hoffman McCann P.C. |
|
|
|
San
Diego, California |
|
June 8, 2021 |
|